サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1121686

光線力学療法の世界市場 - 業界分析、規模、シェア、成長、動向、予測（2022年～2031年）

Photodynamic Therapy Market (Product Type: Photosensitizer Drugs and Devices; and Application: Cancer, Actinic Keratosis, Psoriasis, Acne, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 243 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
光線力学療法の世界市場 - 業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
出版日: 2022年07月21日
発行: Transparency Market Research
ページ情報: 英文 243 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の光線力学療法市場について調査分析し、市場動向、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界の光線力学療法市場

第4章 市場概要

  • イントロダクション
    • セグメントの定義
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界の光線力学療法市場分析と予測（2017年～2031年）
    • 市場収益予測

第5章 主要洞察

  • 主要な合併と買収
  • 技術進歩
  • COVID-19影響分析

第6章 世界の光線力学療法市場分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主要な調査結果/発展
  • 市場の価値予測（2017年～2031年）：製品タイプ別
    • 光増感剤
    • デバイス
  • 市場の魅力分析：製品タイプ別

第7章 世界の光線力学療法市場分析と予測：用途別

  • イントロダクションと定義
  • 主要な調査結果/発展
  • 市場の価値予測（2017年～2031年）：用途別
    • 癌
    • 光線性角化症（AK）
    • 乾癬
    • にきび
    • その他
  • 市場の魅力分析：用途別

第8章 世界の光線力学療法市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主要な調査結果/発展
  • 市場の価値予測（2017年～2031年）：エンドユーザー別
    • 病院
    • CDC
    • CCC
    • その他
  • 市場の魅力分析：エンドユーザー別

第9章 世界の光線力学療法市場分析と予測：地域別

  • 主要な調査結果
  • 市場の価値予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第10章 北米の光線力学療法市場分析と予測

  • イントロダクション
    • 主要な調査結果
  • 市場の価値予測（2017年～2031年）：製品タイプ別
    • 光増感剤
    • デバイス
  • 市場の価値予測（2017年～2031年）：用途別
    • 癌
    • 光線性角化症（AK）
    • 乾癬
    • にきび
    • その他
  • 市場の価値予測（2017年～2031年）：エンドユーザー別
    • 病院
    • CDC
    • CCC
    • その他
  • 市場の価値予測（2017年～2031年）：国別
    • 米国
    • カナダ
  • 市場の魅力分析
    • 製品タイプ別
    • 用途別
    • エンドユーザー別
    • 国別

第11章 欧州の光線力学療法市場分析と予測

第12章 アジア太平洋の光線力学療法市場分析と予測

第13章 ラテンアメリカの光線力学療法市場分析と予測

第14章 中東・アフリカの光線力学療法市場分析と予測

第15章 競合情勢

  • 市場企業 - 競合マトリクス（階層・企業規模別）
  • 市場シェア分析（2021年）：企業別
  • 企業プロファイル
    • Galderma Laboratories, LP
    • Biofrontera AG
    • Excel Lasers Limited
    • LUMIBIRD group（Quantel Medical）
    • Modulight Corporation
    • Quest PharmaTech, Inc.
    • Theralase Technologies, Inc.
    • SUS Advancing Technology Co., Ltd.
図表

List of Tables

  • Table 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
  • Table 03: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
  • Table 04: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
  • Table 05: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 06: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
  • Table 07: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 08: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region , 2017-2031
  • Table 09: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country, 2017-2031
  • Table 10: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type,2017-2031
  • Table 11: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
  • Table 12: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
  • Table 13: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices,2017-2031
  • Table 14: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
  • Table 16: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 19: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drug, 2017-2031
  • Table 20: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
  • Table 21: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
  • Table 22: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
  • Table 24: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 27: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
  • Table 28: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
  • Table 29: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
  • Table 30: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 31: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
  • Table 32: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 33: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 34: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 35: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
  • Table 36: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
  • Table 37: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
  • Table 38: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 39: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
  • Table 40: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 41: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 42: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 43: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
  • Table 44: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017-2031
  • Table 45: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
  • Table 46: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 47: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
  • Table 48: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Photodynamic Therapy Market Value Share (%), by Product Type, 2021
  • Figure 03: Global Photodynamic Therapy Market Value Share (%), by Drugs, 2021
  • Figure 04: Global Photodynamic Therapy Market Value Share (%), by Application, 2021
  • Figure 05: Global Photodynamic Therapy Market Value Share (%), by Region, 2021
  • Figure 06: Global Photodynamic Therapy Market Value Share (%), by Product Type, 2017 and 2031
  • Figure 07: Global Photodynamic Therapy Market Value Share (%), by Photosensitizer Drugs, 2017 and 2031
  • Figure 08: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Photosensitizer Drugs, 2017-2031
  • Figure 09: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Devices, 2017-2031
  • Figure 10: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Porphyrin Derivative (PD), 2017-2031
  • Figure 11: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aminolevulinic Acid (ALA), 2017-2031
  • Figure 12: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chlorines, 2017-2031
  • Figure 13: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
  • Figure 14: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DFOLDD, 2017-2031
  • Figure 15: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diode Laser, 2017-2031
  • Figure 16: Global Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 17: Global Photodynamic Therapy Market Attractiveness Analysis, by Photosensitizer Drugs, 2021-2031
  • Figure 18: Global Photodynamic Therapy Market Attractiveness Analysis, by Devices, 2021-2031
  • Figure 19: Global Photodynamic Therapy Market Value Share (%), by Application, 2017 and 2031
  • Figure 20: Global Photodynamic Therapy Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 21: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer, 2017-2031
  • Figure 22: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Actinic Keratosis (AK), 2017-2031
  • Figure 23: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Psoriasis, 2017-2031
  • Figure 24: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Acne, 2017-2031
  • Figure 25: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
  • Figure 26: Global Photodynamic Therapy Market Value Share (%), by End-user, 2017 and 2031
  • Figure 27: Global Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 28: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2031
  • Figure 29: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmetics & Dermatology Clinics, 2017-2031
  • Figure 30: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer Treatment Centers, 2017-2031
  • Figure 31: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
  • Figure 32: Global Photodynamic Therapy Market Value Share Analysis, by Region, 2017 and 2031
  • Figure 33: Global Photodynamic Therapy Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 34: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 35: North America Photodynamic Therapy Market Value Share (%), by Country, 2017 and 2031
  • Figure 36: North America Photodynamic Therapy Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 37: North America Photodynamic Therapy Market Value Share, by Product Type, 2017and 2031
  • Figure 38: North America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 39: North America Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
  • Figure 40: North America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 41: North America Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
  • Figure 42: North America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 43: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 44: Europe Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017and 2031
  • Figure 45: Europe Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 46: Europe Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
  • Figure 47: Europe Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 48: Europe Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
  • Figure 49: Europe Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 50: Europe Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
  • Figure 51: Europe Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 52: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 53: Asia Pacific Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031
  • Figure 54: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 55: Asia Pacific Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
  • Figure 56: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 57: Asia Pacific Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
  • Figure 58: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 59: Asia Pacific Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
  • Figure 60: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 61: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 62: Latin America Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031
  • Figure 63: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 64: Latin America Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
  • Figure 65: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2017-2031
  • Figure 66: Latin America Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
  • Figure 67: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 68: Latin America Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
  • Figure 69: Latin America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 70: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 71: Middle East & Africa Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031
  • Figure 72: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 73: Middle East & Africa Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
  • Figure 74: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 75: Middle East & Africa Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
  • Figure 76: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 77: Middle East & Africa Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
  • Figure 78: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022-2031
目次
Product Code: TMRGL69615

The report provides revenue of the global photodynamic therapy market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global photodynamic therapy market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the photodynamic therapy market.

The report delves into the competitive landscape of the global photodynamic therapy market. Key players operating in the global photodynamic therapy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global photodynamic therapy market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Photodynamic Therapy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Photodynamic Therapy Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Mergers & Acquisitions
  • 5.2. Technological Advancements
  • 5.3. Covid-19 Impact Analysis

6. Global Photodynamic Therapy Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Photosensitizer Drugs
      • 6.3.1.1. Porphyrin Derivative (PD)
        • 6.3.1.1.1. Hematoporphyrin Derivative (HpD)
        • 6.3.1.1.2. Benzoporphyrin Derivative (BPD)
        • 6.3.1.1.3. Texaphyrins
        • 6.3.1.1.4. Others
      • 6.3.1.2. Aminolevulinic acid (ALA)
      • 6.3.1.3. Chlorines
      • 6.3.1.4. Others
    • 6.3.2. Devices
      • 6.3.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
      • 6.3.2.2. Diode Laser
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Photodynamic Therapy Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Cancer
      • 7.3.1.1. Basal Cell Carcinoma
      • 7.3.1.2. Non-Small Cell Lung Cancer
      • 7.3.1.3. Head & Neck Cancer
      • 7.3.1.4. Others
    • 7.3.2. Actinic Keratosis (AK)
    • 7.3.3. Psoriasis
    • 7.3.4. Acne
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Photodynamic Therapy Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. C&DC
    • 8.3.3. CCC
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Photodynamic Therapy Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Photodynamic Therapy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Photosensitizer Drugs
      • 10.2.1.1. Porphyrin Derivative (PD)
        • 10.2.1.1.1. Hematoporphyrin Derivative (HpD)
        • 10.2.1.1.2. Benzoporphyrin Derivative (BPD)
        • 10.2.1.1.3. Texaphyrins
        • 10.2.1.1.4. Others
      • 10.2.1.2. Aminolevulinic acid (ALA)
      • 10.2.1.3. Chlorines
      • 10.2.1.4. Others
    • 10.2.2. Devices
      • 10.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
      • 10.2.2.2. Diode Laser
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Cancer
      • 10.3.1.1. Basal Cell Carcinoma
      • 10.3.1.2. Non-Small Cell Lung Cancer
      • 10.3.1.3. Head & Neck Cancer
      • 10.3.1.4. Others
    • 10.3.2. Actinic Keratosis (AK)
    • 10.3.3. Psoriasis
    • 10.3.4. Acne
    • 10.3.5. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. C&DC
    • 10.4.3. CCC
    • 10.4.4. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Photodynamic Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Photosensitizer Drugs
      • 11.2.1.1. Porphyrin Derivative (PD)
        • 11.2.1.1.1. Hematoporphyrin Derivative (HpD)
        • 11.2.1.1.2. Benzoporphyrin Derivative (BPD)
        • 11.2.1.1.3. Texaphyrins
        • 11.2.1.1.4. Others
      • 11.2.1.2. Aminolevulinic acid (ALA)
      • 11.2.1.3. Chlorines
      • 11.2.1.4. Others
    • 11.2.2. Devices
      • 11.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
      • 11.2.2.2. Diode Laser
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Cancer
      • 11.3.1.1. Basal Cell Carcinoma
      • 11.3.1.2. Non-Small Cell Lung Cancer
      • 11.3.1.3. Head & Neck Cancer
      • 11.3.1.4. Others
    • 11.3.2. Actinic Keratosis (AK)
    • 11.3.3. Psoriasis
    • 11.3.4. Acne
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. C&DC
    • 11.4.3. CCC
    • 11.4.4. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Photodynamic Therapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Photosensitizer Drugs
      • 12.2.1.1. Porphyrin Derivative (PD)
        • 12.2.1.1.1. Hematoporphyrin Derivative (HpD)
        • 12.2.1.1.2. Benzoporphyrin Derivative (BPD)
        • 12.2.1.1.3. Texaphyrins
        • 12.2.1.1.4. Others
      • 12.2.1.2. Aminolevulinic acid (ALA)
      • 12.2.1.3. Chlorines
      • 12.2.1.4. Others
    • 12.2.2. Devices
      • 12.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
      • 12.2.2.2. Diode Laser
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Cancer
      • 12.3.1.1. Basal Cell Carcinoma
      • 12.3.1.2. Non-Small Cell Lung Cancer
      • 12.3.1.3. Head & Neck Cancer
      • 12.3.1.4. Others
    • 12.3.2. Actinic Keratosis (AK)
    • 12.3.3. Psoriasis
    • 12.3.4. Acne
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. C&DC
    • 12.4.3. CCC
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Photodynamic Therapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Photosensitizer Drugs
      • 13.2.1.1. Porphyrin Derivative (PD)
        • 13.2.1.1.1. Hematoporphyrin Derivative (HpD)
        • 13.2.1.1.2. Benzoporphyrin Derivative (BPD)
        • 13.2.1.1.3. Texaphyrins
        • 13.2.1.1.4. Others
      • 13.2.1.2. Aminolevulinic acid (ALA)
      • 13.2.1.3. Chlorines
      • 13.2.1.4. Others
    • 13.2.2. Devices
      • 13.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
      • 13.2.2.2. Diode Laser
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Cancer
      • 13.3.1.1. Basal Cell Carcinoma
      • 13.3.1.2. Non-Small Cell Lung Cancer
      • 13.3.1.3. Head & Neck Cancer
      • 13.3.1.4. Others
    • 13.3.2. Actinic Keratosis (AK)
    • 13.3.3. Psoriasis
    • 13.3.4. Acne
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. C&DC
    • 13.4.3. CCC
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Photosensitizer Drugs
      • 14.2.1.1. Porphyrin Derivative (PD)
        • 14.2.1.1.1. Hematoporphyrin Derivative (HpD)
        • 14.2.1.1.2. Benzoporphyrin Derivative (BPD)
        • 14.2.1.1.3. Texaphyrins
        • 14.2.1.1.4. Others
      • 14.2.1.2. Aminolevulinic acid (ALA)
      • 14.2.1.3. Chlorines
      • 14.2.1.4. Others
    • 14.2.2. Devices
      • 14.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
      • 14.2.2.2. Diode Laser
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Cancer
      • 14.3.1.1. Basal Cell Carcinoma
      • 14.3.1.2. Non-Small Cell Lung Cancer
      • 14.3.1.3. Head & Neck Cancer
      • 14.3.1.4. Others
    • 14.3.2. Actinic Keratosis (AK)
    • 14.3.3. Psoriasis
    • 14.3.4. Acne
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. C&DC
    • 14.4.3. CCC
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2021
  • 15.3. Company Profiles
    • 15.3.1. Galderma Laboratories, L.P.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Biofrontera AG
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. 15.3.1.5. Recent Developments
    • 15.3.3. Excel Lasers Limited
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. LUMIBIRD group (Quantel Medical)
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Modulight Corporation
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Quest PharmaTech, Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Theralase Technologies, Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. SUS Advancing Technology Co., Ltd.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments